Biogen FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Nov 4, 2022
  • No warning letters matched by name
Inspections 13 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 2 Latest Nov 22, 2004

Biogen has 0 FDA recalls, 13 inspections, 2 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Biogen" is on file.

What these totals cover: FDA records filed under the name "Biogen". Records filed under related names are not included; see Related names.

Latest inspection
Nov 4, 2022 · NAI
Latest 510(k)
Nov 22, 2004

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances2Nov 22, 2026File dated Nov 18, 2026Current
Inspections13Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Biogen's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Biogen: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202220000
202100000
202020000
201900000
201810000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Biogen as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Biogen yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

13 inspections from Sep 30, 2009 to Nov 4, 2022.

DateSiteProductClassificationFEI
Nov 4, 2022Cambridge, MADrugsNo Action Indicated (NAI)1220951
Sep 2, 2022Cambridge, MADrugsNo Action Indicated (NAI)1220951
Nov 10, 2020Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Sep 1, 2020Cambridge, MADrugsNo Action Indicated (NAI)1220951
Feb 13, 2018Cambridge, MABiologicsNo Action Indicated (NAI)1220951
Apr 6, 2017Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Feb 9, 2016Cambridge, MABiologicsVoluntary Action Indicated (VAI)1220951
Jun 26, 2015Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Jul 3, 2014Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Mar 15, 2013Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Jun 27, 2012Cambridge, MADrugsNo Action Indicated (NAI)1220951
Sep 8, 2010Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
Sep 30, 2009Cambridge, MADrugsVoluntary Action Indicated (VAI)1220951
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1220951Cambridge, MA13Nov 4, 2022

Recent 510(k) clearances

2 510(k) clearances from Nov 5, 2003 to Nov 22, 2004.

K-NumberDeviceDate
K042314SYRINGE GRIP FOR THE AVONEX PRE-FILLED SYRINGENov 22, 2004
K032425INVISIJECT RESUSABLE AUTO-INJECTORNov 5, 2003

Biogen and the FDA: common questions

Has Biogen received an FDA warning letter?

No FDA warning letter addressed to the name "Biogen" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Biogen received an FDA Form 483?

FDA has not published a Form 483 for "Biogen" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Biogen?

The most recent FDA inspection on file ended Nov 4, 2022 at Cambridge, MA and was classified NAI. FDA has 13 inspections of Biogen on file.

Need more than this page shows? Ask about Biogen in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.